Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Warsaw Stock Exchange  >  Pharmena S.A.    PHR   PLPHRMN00011

PHARMENA S.A.

(PHR)
  Report
End-of-day quote. End-of-day quote Warsaw Stock Exchange - 11/30
10.9 PLN   -3.11%
 SummaryChartsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Warsaw Stock Exchange
11/24/2020 11/25/2020 11/26/2020 11/27/2020 11/30/2020 Date
11.9 11.4 11.3 11.25 10.9 Last
8023 9276 13819 7747 4861 Volume
-2.86% -4.20% -0.88% -0.44% -3.11% Change
Financials
Sales 2018 13,0 M 3,48 M 3,48 M
Net income 2018 -0,44 M -0,12 M -0,12 M
Net Debt 2018 0,60 M 0,16 M 0,16 M
P/E ratio 2018 -132x
Yield 2018 -
Sales 2019 11,1 M 2,97 M 2,97 M
Net income 2019 -9,43 M -2,52 M -2,52 M
Net Debt 2019 2,44 M 0,65 M 0,65 M
P/E ratio 2019 -5,70x
Yield 2019 -
Capitalization 120 M 31,9 M 32,0 M
EV / Sales 2018 4,53x
EV / Sales 2019 5,52x
Nbr of Employees -
Free-Float 32,6%
More Financials
Company
Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of... 
Sector
Personal Products
Calendar
-
More about the company
All news about PHARMENA S.A.

- No features available -

More news
News in other languages on PHARMENA S.A.
2016ORIGINAL-RESEARCH : Pharmena S.A. (von East Value Research GmbH ):
More news
Chart PHARMENA S.A.
Duration : Period :
Pharmena S.A. Technical Analysis Chart | PHR | PLPHRMN00011 | MarketScreener
Technical analysis trends PHARMENA S.A.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Managers
NameTitle
Konrad Palka President, Chairman-Management Board & CEO
Jerzy Gebicki Chairman-Supervisory Board
Marzena Wieczorkowska Vice President-Research & Development
Anna Sysa-Jedrzejowska Member-Supervisory Board
Jan Adamus Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
PHARMENA S.A.103.36%32
L'ORÉAL16.21%205 121
KAO CORPORATION-13.48%35 986
SHISEIDO COMPANY, LIMITED-5.42%28 175
NATURA &CO HOLDING S.A.30.36%12 887
AMOREPACIFIC CORPORATION-10.50%9 851